As such, adrenal gland, bladder, thyroid, brain, esophagus, stomach, colon, ovary, uterus, pancreas, skin, kidney, liver, lung, breast, testis, prostate, and cervix cancers that classically overexpress Ran [49] could benefit from oVSV therapy. This evidence concerns the gene RAN and cervical cancer.